Sodium Bicarbonate → HCID 89457107, compound
Reaction equation
[F:1][CH:2]([F:27])[CH2:3][N:4]1[C:8]([N:9]2[CH2:15][CH:14](O)[CH2:13][N:12]([C:17]([O:19][C:20]([CH3:23])([CH3:22])[CH3:21])=[O:18])[CH2:11][CH2:10]2)=[C:7]([N+:24]([O-:26])=[O:25])[CH:6]=[N:5]1.COCCN(S(F)(F)[F:38])CCOC.C([O-])(O)=O.[Na+]>C(Cl)Cl.C1COCC1>[F:1][CH:2]([F:27])[CH2:3][N:4]1[C:8]([N:9]2[CH2:15][CH:14]([F:38])[CH2:13][N:12]([C:17]([O:19][C:20]([CH3:23])([CH3:22])[CH3:21])=[O:18])[CH2:11][CH2:10]2)=[C:7]([N+:24]([O-:26])=[O:25])[CH:6]=[N:5]1Participants
Procedure
To a solution of tert-butyl 4-(1-(2,2-difluoroethyl)-4-nitro-1H-pyrazol-5-yl)-6-hydroxy-1,4-diazepane-1-carboxylate (370 mg, 0.95 mmol) in DCM (10 mL) was added deoxo-Fluor® (50% solution in THF, 1.0 mL, 2.37 mmol) and the mixture was stirred at room temperature for 18 hr. Saturated aqueous NaHCO3 solution (10 mL) was added slowly and the mixture was stirred for 15 min. The aqueous layer was extracted with DCM (10 mL), the combined organic layers were passed through a phase separation cartridge and the solvent was removed under reduced pressure. Purification via silica gel column chromatography gave tert-butyl 4-(1-(2,2-difluoroethyl)-4-nitro-1H-pyrazol-5-yl)-6-fluoro-1,4-diazepane-1-carboxylate as a pale green gum (366 mg, 74%). 1H NMR (400 MHz, CDCl3) δ 8.12 (s, 1H), 6.34-6.00 (m, 1H), 5.08-2.75 (m, 11H), 1.48 (s, 9H).
Workup
- stirringthe mixture was stirred for 15 min
- extractionThe aqueous layer was extracted with DCM (10 mL)
- customthe combined organic layers were passed through a phase separation cartridge
- customthe solvent was removed under reduced pressure
- customPurification via silica gel column chromatography
Sources & evidence
- ORD record
- ord-fed144691d2143449acd80920048388e
- Source dataset
- uspto-grants-2013_12
- Patent number
- US08614206B2
Reaction notes
Loading…